Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) Return on Assets (2016 - 2025)

Altimmune (ALT) has disclosed Return on Assets for 15 consecutive years, with 0.41% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets rose 23.0% to 0.41% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.41%, a 23.0% increase, with the full-year FY2024 number at 0.54%, down 12.0% from a year prior.
  • Return on Assets was 0.41% for Q3 2025 at Altimmune, up from 0.51% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.04% in Q1 2021 to a low of 0.66% in Q4 2024.
  • A 5-year average of 0.41% and a median of 0.43% in 2023 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: surged 39bps in 2021, then tumbled -36bps in 2022.
  • Altimmune's Return on Assets stood at 0.34% in 2021, then fell by -14bps to 0.39% in 2022, then dropped by -20bps to 0.47% in 2023, then tumbled by -41bps to 0.66% in 2024, then surged by 38bps to 0.41% in 2025.
  • Per Business Quant, the three most recent readings for ALT's Return on Assets are 0.41% (Q3 2025), 0.51% (Q2 2025), and 0.61% (Q1 2025).